冠状动脉介入术后强化他汀类药物治疗的意义
被引量:3
摘要
冠状动脉介入术(PCI)围手术期缺血综合征及术后并发症严重影响了患者的预后,甚至增加死亡风险,因此需要寻找一种全身的治疗方案、调整引发急性冠状动脉综合征(ACS)靶点的生物特性及如何改善PCI术后患者围手术期及远期预后已经成为目前心血管领域备受关注的焦点。既往非随机研究显示他汀类药物类药物治疗是PCI术后生存获益的独立预测因子,
出处
《心肺血管病杂志》
CAS
2011年第1期82-84,共3页
Journal of Cardiovascular and Pulmonary Diseases
参考文献20
-
1Cannon CP,Steinberg BA,Mushy SA,et al.Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.J Am Coll Cardiol,2006,48:438-445.
-
2Expert panel on detection,evaluationg,and treatment of high blood cholesterol in adults.Executive summary of the third report of thenational cholesterol education program(NCEP)expert panel on detection,evaluationg,and treatment of high blood cholesterol in adults(Adult treatment panel Ⅲ).JAMA,2001,285:2486-2497.
-
3Grundy SM,Cleeman JI,Merz CN,et al.Implications of rccent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guidelines.Circulation,2004,110:227-239.
-
4Serruys PW,De Feyter PJ,Benghozi R,et al.The Lescol(R)intervention prevention study(UPS):a double-blind,placebo-controlled,randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease.Int J Cardiovasc Intervent,2001,4:165-172.
-
5Davignon J.Beneficial cardiovascular phiotropic effects of st-atins.Circulation,2004,109:Ⅲ,39-43.
-
6Williams JK,Sukhova GK,Herrington DM,et al.Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.J Am Coll Cardiol.1998:684-691.
-
7吕琳,罗静,鹿克风.氟伐他汀对实验性动脉粥样硬化家兔血管壁NF-κB表达的影响[J].心肺血管病杂志,2006,25(1):43-45. 被引量:9
-
8Stefanadis C,Toutouzas K,Vavuranakis M,et al.Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques.Eur Heart J,2002:1664-1669.
-
9Puccetti L,Bruni F,Bova G,et al.Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolcmic subjects.Nutr Metab Cardiovase Dis,2001,11:378-387.
-
10赵卓,吴学思.他汀类药物在急性冠状动脉综合征中的抗炎地位[J].心肺血管病杂志,2005,24(1):58-60. 被引量:3
二级参考文献30
-
1Thompson GR,Hollyer J,Waters DD.Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease.Curr Opin Lipidol,1995,6:386-388.
-
2Jukema JW, Bruschke AVG, Boven AJ,et al.Effects of lipid lowering by provastatin on progression and regression of coronary heart disease in symptomatic men with normal to moderately elevated serum cholesterol levels:the Regression Growth Evaluation Statin Study(REGRESS).Circulation, 1995,91:2528-2540.
-
3Moreno PR, Falk E, Palacios IF,et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation, 1994,90:775-778.
-
4Idrissia A,Nicolas D,Claudio I,et al.C-Reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes.Am Heart J, 1999,137:346-351.
-
5Lindahl B,Toss H,Siegbahn A,et al.Markers of myocardiol damage and inflammation inrelation to long term mortality in unstable coronary artery disease.FRISC study group.fragmin during instability in coronary artery disease. N Engl J Med,2000,343:1139.
-
6Winter RJ.Independent Prognostic Value of C-reactive protein and troponin Iin patients with unstable angina of non-Q-wave myocardial Infarction.Cardiovasc Res, 1999,42:240-245.
-
7Biasucci LM,Liuzzo G,Grillo RL,et al.Elevated levels of C-reactiva protein at discharge in patients with unstable angina predict recurrent instability.Circulation, 1999,99:855-860.
-
8Ferreiros ER,Boissonnet CP,Pizarro R,et al.Independent prognostic value of elevated C-reactive protein in unstable angina.Circulation, 1999,100:1958-1963.
-
9Becker RC,Cannon CP, Bovil EG,et al.Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave myocardial infarction.Am J Cardiol, 1996,78:142-147.
-
10Libby P,Ridker PM, Maseri Attilio.Inflammation and atherosclerosis.Circulation, 2002,105:1135-1143.
共引文献10
-
1孙彬,王蕴红.NF-κB与炎症性疾病和心脏病的关系[J].菏泽医学专科学校学报,2006,18(4):87-89. 被引量:1
-
2张晶,吴尚洁.高脂饮食兔肺泡巨噬细胞NF-κB的表达及立普妥对其影响[J].心肺血管病杂志,2007,26(2):114-117. 被引量:1
-
3武晓菊,鹿育萨.阿托伐他汀对动脉粥样硬化兔脑组织炎性反应的干预作用[J].中国脑血管病杂志,2008,5(1):27-31. 被引量:3
-
4马晶,胡春燕,黄波,蒋庆渊.辛伐他汀对T淋巴细胞抗炎机制的研究[J].心肺血管病杂志,2009,28(3):195-197. 被引量:2
-
5张军平,许颖智,李明,李良军,彭立,张光银,杨萃,周亚男.补肾抗衰片对实验性动脉粥样硬化家兔的NF-κB及炎症因子的影响[J].中国中西医结合杂志,2009,29(9):816-820. 被引量:31
-
6贾丽君,刘素筠.辛伐他汀对糖尿病大鼠颈动脉中P-选择素表达的影响[J].中国医疗前沿,2009,4(18):5-6.
-
7许颖智,张军平,李明,李良军,彭立,张光银,杨萃,周亚男.四妙勇安汤对动脉粥样硬化斑块易损指数的影响及机制探讨[J].中华中医药杂志,2010,25(12):2298-2301. 被引量:14
-
8王冠,李艳芳.阿昔莫司和阿托伐他汀对血浆脂蛋白(a)作用的比较[J].心肺血管病杂志,2011,30(1):4-7. 被引量:14
-
9张倩,王春梅,朱小玲.急性冠状动脉综合征患者应用依折麦布联合阿托伐他汀治疗的临床研究[J].心肺血管病杂志,2013,32(3):259-261. 被引量:14
-
10王蕴强.他汀类药物在急性冠状动脉综合征中的抗感染作用[J].中外医学研究,2014,12(14):163-164.
同被引文献26
-
1赵卓,吴学思.他汀类药物在急性冠状动脉综合征中的抗炎地位[J].心肺血管病杂志,2005,24(1):58-60. 被引量:3
-
2王征,胡大一,杨进刚,李田昌,王阳.替罗非班对急性心肌梗死病人PCI术后炎性因子影响的观察[J].中国医药导刊,2006,8(5):330-332. 被引量:6
-
3Rigatelli G,Giordan M,Candaioli Pet al.Lilac artery thrombosis after aortic ballon counterpulsation treatment with intmarterial tirofiban,mamnual thrombectomy and stenting[J].Int J Cardiol,2006,112(3):387-388.
-
4Matsumoto H,Inoue N,Takaoka H,et al.Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction[J].Clin Cardio1,2004,27(8):466-470.
-
5Pandor A,Ara RM,Tumur I,et al.Ezetimibe monotherapy forcholesterol lowering in 2,722 people:systematic review and me-ta-analysis of randomized controlled trials.J Intern Med,2009,265:568-580.
-
6Thygesen K,Alpert JS,White HD,et al.Universal definition ofmyocardial infarction.J Circulation,2007,116:2634-2653.
-
7Pearson TA,Ballantyne CM,Veltri E,et al.Pooled analyses ofeffects on C-reactive protein and low density lipoprotein cholester-ol in placebo-controlled trials of ezetimibe monotherapy orezetimibe added to baseline statin therapy.Am J Cardiol,2009,103:369-374.
-
8Farnier M,Freeman MW,Macdonell G,et al.Efficacy and safe-ty of the coadministration of ezetimmibe with fenofibrate in pa-tients with mixed hyperlipidaemin.Eur Heart J,2005,26:897-905.
-
9Baigent C,Landray MJ,Reith C,et al.The effects of loweringLDL cholesterol with simvastatin plus ezetimibe in patients withchronic kidney disease(Study of Heart and Renal Protection):a randomised placebo-controlled trial.Lancet,2011,377:2181-2192.
-
10Pearson TA,Ballantyne CM,Veltri E,et al.Pooled analyses ofeffects on C-reactive protein and low density lipoprotein cholester-ol in placebo-controlled trials of ezetimibe monotherapy orezetimibe added to baseline statin therapy.Am J Cardiol,2009.103:369-374.
二级引证文献14
-
1俞章平,余晗俏,钟忆周,梁亚非,高文涛.依折麦布联合阿托伐他汀对急性冠状动脉综合征患者血脂指标及血管内皮功能的影响[J].中国生化药物杂志,2014,34(6):110-112. 被引量:24
-
2黄敏琴,罗婷,夏彬一,张丹.HPLC测定(S)-4-苯基-2-噁唑烷酮的纯度[J].华西药学杂志,2015,30(2):238-239.
-
3李华,薛世虎,赵华伟,刘敬兰,职晶晶,黄春媛,闫秀平.基于LDL-C水平评价依折麦布辛伐他汀片对急性冠脉综合征患者预后的影响[J].临床合理用药杂志,2015,8(13):31-32. 被引量:3
-
4吕洋,陈岩,齐文诚,Thanyaluk Charoenkham.他汀类药物联合依折麦布调脂治疗研究进展[J].辽宁中医药大学学报,2015,17(9):208-212. 被引量:6
-
5陈玉环,文轶,林丽莉.依折麦布辅助治疗对冠心病合并高胆固醇血症患者颈动脉粥样硬化斑块的影响[J].现代医院,2015,15(1):53-55. 被引量:4
-
6王东.阿托伐他汀联合依折麦布治疗急性冠脉综合征的临床效果分析[J].国际医药卫生导报,2016,22(13):1946-1948. 被引量:3
-
7黎敏如,王伟才,罗桃.氟西汀联合阿司匹林肠溶片、阿托伐他汀片治疗老年急性冠脉综合征患者抑郁的效果观察[J].中国医药科学,2017,7(4):81-83. 被引量:3
-
8高瑞迁.阿托伐他汀联合依折麦布治疗急性冠状动脉综合征患者的临床疗效[J].中国药物经济学,2017,12(4):75-77. 被引量:4
-
9朱梅生,周晓辉.早期阿托伐他汀联合依折麦布治疗急性冠脉综合征临床疗效[J].药品评价,2016,13(14):48-50. 被引量:4
-
10王斌.阿托伐他汀联合依折麦布治疗急性冠状动脉综合征的临床疗效分析[J].中国医药指南,2017,15(24):124-125. 被引量:4
-
1叶林书.冠状动脉缺血综合征治疗研究进展[J].医学理论与实践,1999,12(9):509-511.
-
2赵丽,张翥.C反应蛋白与动脉粥样硬化[J].国际内科学杂志,2007,34(2):119-121. 被引量:15
-
3张立,林勇.降钙素原在呼吸系统感染性疾病诊断及治疗中的应用[J].东南大学学报(医学版),2011,30(4):643-648. 被引量:51
-
4张海涛,吴清玉.内皮素的临床研究进展[J].心血管病学进展,1999,20(3):131-133. 被引量:36
-
5吴其恺.肝衰竭肠源性内毒素血症的研究进展[J].传染病信息,2009,22(5):316-319. 被引量:9
-
6邱志兵.内皮素与心肌缺血再灌注损伤[J].国外医学(老年医学分册),2001,22(4):158-161. 被引量:11
-
7刘莉,周玉娟.氧化低密度脂蛋白在动脉粥样硬化中的作用机制[J].中国中医药咨讯,2010(33):18-20. 被引量:3
-
8罗妙玲.心肌标志物在心脏疾病诊断研究的新进展[J].健康必读(下),2010,1(9):50-50.
-
9吕才模,林国跃.B型钠尿肽与心力衰竭研究现状[J].现代生物医学进展,2008,8(4):740-743. 被引量:3
-
10肖海鹏.如何改善糖尿病伴冠状动脉粥样硬化性心脏病患者的预后[J].新医学,2002,33(8):501-503. 被引量:13